original: clinical trials with als patients showed that riluzole lengthens survival by several months , and may have a greater survival benefit for those with a bulbar onset .
simplifications: riluzole prolongs survival by several months and could benefit those with bulbar onset and this was observed during clinical trials with als patients for people who have als , the medicine riluzole proved that it helps the patients live longer , and might help people who just got the disease even more . clinical trials with als patients showed that riluzole lengthens survival by several months , and may have a greater survival benefit for those with a bulbar onset . clinical trials with als patients showed that riluzole makes life last several months longer , and may give those with a bulbar onset a better chance of living . good news for als patients with a bulbar onset , is that clinical trials have proved that riluzole lengthens survival by several months , and may have a greater survival benefit . clinical trials with als patients showed that riluzole lengthens people 's lives by several months , and may have a greater survival benefit for those with a bulbar onset . clinical trials with als patients showed that riluzole lengthens survival by many months and may have a greater survival benefit for those with a bulbar onset . scientific fact-finding experiments with als patients showed that riluzole lengthens survival by several months , and may have a greater survival benefit for those with a bulbar beginning .